Filing Flows › Comparisons › PAHC vs PTCT
Phibro Animal Health vs PTC Therapeutics: PAHC and PTCT compared
Phibro Animal Health is the larger company: $387M of revenue in its latest quarter (Q1 FY27) against $358M for PTC Therapeutics (Q3 2026). PTC Therapeutics is growing faster (+70% against +6% a year earlier). Phibro Animal Health is more profitable, with an operating margin of 12.8% against 7.0%.
Where the money goes: PAHC and PTCT
Phibro Animal Health (PAHC) · Q1 FY27
Phibro Animal Health, Q1 FY27: revenue $387M (+6% year over year), operating margin 12.8%, net earnings $29.5M, operating cash flow $26.1M. The chart follows the revenue to costs, profit and cash.
PTC Therapeutics (PTCT) · Q3 2026
PTC Therapeutics, Q3 2026: revenue $358M (+70% year over year), operating margin 7.0%, net loss $51.7M, operating cash flow −$25.3M. The chart follows the revenue to costs, profit and cash.
| Phibro Animal Health (PAHC) | PTC Therapeutics (PTCT) | |
|---|---|---|
| Latest quarter | Q1 FY27 | Q3 2026 |
| Revenue | $387M | $358M |
| Revenue growth, Y/Y | +6% | +70% |
| Gross margin | 33.2% | — |
| Operating margin | 12.8% | 7.0% |
| Net earnings | $29.5M | −$51.7M |
| Net margin | 7.6% | -14.4% |
| Operating cash flow | $26.1M | −$25.3M |
| Free cash flow | $7.3M | — |
| Market value | $1.3B | $5.5B |
| P/E | 13.2× | — |
| Analysts’ mean target | $47.00 | $100.47 |
Where the revenue comes from
Phibro Animal Health
- Animal Health: $293M (76%)
- Mineral Nutrition: $73.6M (19%)
- Performance Products: $20.2M (5%)
PTC Therapeutics
- Net product revenue: $276M (77%)
- Royalty revenue: $81.7M (23%)
- Collaboration and license revenue: $229K (0%)
Questions
Which is bigger, Phibro Animal Health or PTC Therapeutics?
Phibro Animal Health is the larger company: $387M of revenue in its latest quarter (Q1 FY27) against $358M for PTC Therapeutics (Q3 2026).
Is Phibro Animal Health or PTC Therapeutics growing faster?
PTC Therapeutics is growing faster (+70% against +6% a year earlier).
Which is more profitable, Phibro Animal Health or PTC Therapeutics?
Phibro Animal Health is more profitable, with an operating margin of 12.8% against 7.0%.
More: Phibro Animal Health earnings · how Phibro Animal Health makes money · PTC Therapeutics earnings · how PTC Therapeutics makes money
From the companies' latest 10-Q, 10-K or earnings release (10-Q filed Nov 4, 2026; 10-Q filed Oct 29, 2026). Fiscal quarters can end on different dates. Not investment advice.